Patent ID: 7737138
Filing Date: 2010-06-15
Classification: A61P,C07D,C09B

Abstract:
1. A method of treatment of Alzheimer's disease (AD) in a patient, comprising administering to said patient a compound selected from the following compounds: (A) ethyl-thioninium chloride (ETC), (B) 1,9-diethyl-methyl-thioninium chloride (DEMTC), (C) 1,9-dimethyl-ethyl-thioninium chloride (DMETC), (D) 1,9-diethyl-ethyl-thioninium chloride (DEETC), (F) ethyl-thioninium chloride zinc chloride mixed salt (ETZ), (I) ethyl-thioninium iodide (ETI), (J) ethyl-thioninium iodide hydrogen iodide mixed salt (ETI.HI), (L) ethyl-thioninium nitrate (ETN).